SavedAdd your journal

Journals / Medical Network Klinik Bilimler ve Doktor / 2004 / Cilt: 10 - Sayı: 3

Comparing the antiemetic effect of prophylactic ondansetron and metoclopramide in cesarean section under spinal anaesthesia

Spinal anestezi ile sezaryen operasyonlarında profilaktik ondansetron ve metoklopramidin antiemetik etkinliklerinin araştırılması

JALE BENGİ ÇELİK
Ruhiye REİSLİ
KAZIM GEZGİNÇ
Sema TUNCER
Selmin ÖKESLİ
Cemalettin AKYÜREK
Pages
343–347
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, there is no difference between ondansentron and metoclopramide in reducing frequency of vomiting postoperative period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The efficacy of ondansentron and metoclopramide were evaluated for prophylactic treatment of nausea and vomiting in cesarean section patients under spinal anaesthesia.
📊
Key Findings & Data:Materials and Methods: Sixty ASA physical status I-II parturients requiring cesarean section gave this consent and were randomly assigned into one of three treatments groups (n=20) according to a double-blind, placebo-controlled protocol.
💡
Conclusion & Impact:However, there is no difference between ondansentron and metoclopramide in reducing frequency of vomiting postoperative period.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ameliyat sonrası bulantı ve kusma · Anestezi · spinal

Abstract

Objective: The efficacy of ondansentron and metoclopramide were evaluated for prophylactic treatment of nausea and vomiting in cesarean section patients under spinal anaesthesia. Materials and Methods: Sixty ASA physical status I-II parturients requiring cesarean section gave this consent and were randomly assigned into one of three treatments groups (n=20) according to a double-blind, placebo-controlled protocol. After umblical cord clamping, ondansentron 8 mgr (Group I), metoclopramide 10 mgr (Group II), 0.9% saline (Group III) were injected intravenously. Episodes of nausea and vomiting, resque antiemetic requirement and side effects were recorded. Results: The frequency of intraoperative nausea were 20.3%, 46% and 60% for group I, II and III respectively (p<0.05). The frequency of intraoperative vomiting 6%, 33%, 53% for group I, II and III respectively (p<0.05). The frequency of postoperative 24 hour period nausea were 23%, 48%, 69% for group I, II and III respectively (p<0.05) and vomiting were similiar between group I and II but significantly higher in group III (p<0.05). Resque antiemetic requirement were lower in group I than group II and group III (p<0.05). Side effects were not significantly amoung groups. Conclusion: In cesarean section under spinal anaesthesia, prophylactic ondansentron 8 mgr intravenously is more efficacious than metoclopramide 10 mgr intravenously or placebo in preventing nausea during first 24 hour postoperative period. However, there is no difference between ondansentron and metoclopramide in reducing frequency of vomiting postoperative period.

Özet

Amaç: Spinal anestezi altında sezaryen operasyonu geçiren olgularda bulantı ve kusmanın profilaktik tedavisinde ondansentron ve metoklopramidin etkinliği araştırıldı. Gereç ve Yöntem: ASA I-II grubunda sezaryen operasyonu gerektiren 60 gebe rastgele 3 gruptan birine alındı (n=20) ve çift-kür, plasebo kontrollü protokol uygulandı. Umbilikal kord klamplendikten sonra, 8 mgr ondansentron (grup I), 10 mgr metoklopramidin (grup II) ve %0.9 saline (grup III) intravenöz olarak verildi. Bulantı ve kusma epizodları, ek antiemetik gereksinimi ve yan etkileri kaydedildi. Bulgular: İntraoperatif bulantı insidansı Grup I, II ve III'te sırası ile %20.3, %46 ve %60 idi (p<0.05). İntraoperatif kusma insidansı Grup I, II ve III'te sırası ile %6, %33 ve %53 olarak bulundu (p<0.05). Postoperatif 24 saatlik dönemde kusma insidansı %6, %33 ve %53 iken (p< 0.05) postoperatif 24 saatte bulantı insidansı Grup I ve II'de benzer fakat Grup III' te anlamlı derecede yüksekti (p<0.05). Ek antiemetik gereksinimi Grup I'de Grup II ve III'e göre anlamlı derecede düşüktü (p< 0.05). Yan etkileri bakımından gruplar arasında fark yoktu. Sonuç: Spinal anestezi altındaki sezaryen operasyonlarında intravenöz 8 mgr verilen profilaktik ondansentron intraoperatif bulantı ve kusma, postoperatif bulantının önlenmesinde 10 mgr intravenöz metoklopramidin veya plasebodan çok daha etkili bulundu. Bununla birlikte postoperatif kusmanın frekansında ondansentron ile metoklopramidin arasında fark bulunmadı.

🔖

Cite This Article

ÇELİK, J. B., REİSLİ, R., GEZGİNÇ, K., TUNCER, S., ÖKESLİ, S., AKYÜREK, C. (2004). Comparing the antiemetic effect of prophylactic ondansetron and metoclopramide in cesarean section under spinal anaesthesia. Medical Network Klinik Bilimler ve Doktor, Cilt: 10 - Sayı: 3, 343–347. https://ajindex.com/articles/279125

References (12)

  1. Watcha MF, White PF. Postoperative nausea and vomiting:its etiology, treatment and prevention. Anesthesiology 1992; 7:162-84. Sung YF. Risks and benefits of drugs used in the ianagement of postoperative nausea and vomiting. Drug Safety 1996; 14:181 -97. Santos A, Datta S. Prophylactic use of droperidol for control of nausea and vomiting during spinal anesthesia for cesarean ection. Anesth Analg 1984; 63:85-7.
  2. Lussos SA, Bader AM, Thornhill ML, Datta S. The antiemetic fficacy and safety of prophylactic metoclopramide for elective esarean section delivery during spinal anesthesia. Reg Anesth 992; 17:126-30.
  3. Pan PH, Moore CH. Intraoperative antiemetic efficacy of prophylactic ondansentron versus droperidol for cesarean section patients under epidural anesthesia. Anesth Analg 1996;83:982-6.
  4. Lee PJ, Pandit SK, Green CR. Postanesthetic side effects in he outpatient. Which are the most important? Anesthesia and Analgesia 1995; 80(Suppl):271. Chestnut DH, Vandewalker GE, Owen CL, et al. Vdministration of metoclopramide for prevention of nausea and 'omiting during epidural -anesthesia for elective cesarean section. Anesthesiology 1987; 66:563-6.
  5. Madej TH, Simpson KH. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynecological surgery. Br J Anesth 1986; 58:884-7.
  6. Vella L, Francis D, Houlton P, Reynolds F. Comparison of the antiemetic metoclopramide and promethazine in labour. BMJ 1985;290:1173-5.
  7. Cubeddu LX, Hoffman IS, Fuenmayor NT, Finn AL. Efficacy of ondansentron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 1990; 322:810-6.
  8. Blackwell CP, Harding SM. The clinical pharmacology of ondansentron. Eur J Cancer Clin Oncol 1989; 25:21-4.
  9. Quinn AC, Brown JH, Wallace PG, AsburyAJ. Studies in postoperative sequelae. Nausea and vomiting- still a problem. Anesthesia 1994; 49:62-5.
  10. Pataky AO, Kitz DS, Andrews RW, Lecky JH. Nausea and vomiting following ambulatory surgery: are all procedures created equal? Anesthesia and Analgesia 1988; 67:163. Gold Ml. Postanaesthetic vomiting in the recovery room. British Journal of Anesthesia 1969; 41:143-9.
  11. Polati E, Verlato G, Finco G, et al. Ondansentron versus Metoclopramide in the treatment of Postoperative Nausea and Vomiting. Anesth Analg 1997; 85:395-9.
  12. Diemunsch P, Conseillei1 C, ClytiN, Mamet J P. The French Ondansentron Study Group Ondansentron compared with metoclopramide in the treatment of established